[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Neogenomics Inc (NEO)

Neogenomics Inc (NEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,918,023
  • Shares Outstanding, K 130,212
  • Annual Sales, $ 727,330 K
  • Annual Income, $ -108,030 K
  • EBIT $ -106 M
  • EBITDA $ -36 M
  • 60-Month Beta 1.74
  • Price/Sales 2.55
  • Price/Cash Flow 42.50
  • Price/Book 2.24

Options Overview Details

View History
  • Implied Volatility 91.46% (+21.00%)
  • Historical Volatility 65.59%
  • IV Percentile 76%
  • IV Rank 18.25%
  • IV High 315.47% on 03/13/26
  • IV Low 41.44% on 08/15/25
  • Expected Move (DTE 6) 0.00 (0.00%)
  • Put/Call Vol Ratio 0.13
  • Today's Volume 34
  • Volume Avg (30-Day) 188
  • Put/Call OI Ratio 0.07
  • Today's Open Interest 12,458
  • Open Int (30-Day) 11,261
  • Expected Range 14.11 to 14.11

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.06
  • Number of Estimates 3
  • High Estimate $-0.04
  • Low Estimate $-0.07
  • Prior Year $-0.06
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
10.05 +40.40%
on 06/16/26
15.57 -9.38%
on 07/06/26
+2.83 (+25.09%)
since 06/10/26
3-Month
7.62 +85.17%
on 04/13/26
15.57 -9.38%
on 07/06/26
+6.42 (+83.49%)
since 04/10/26
52-Week
4.72 +198.94%
on 08/01/25
15.57 -9.38%
on 07/06/26
+6.62 (+88.38%)
since 07/10/25

Most Recent Stories

More News
NeoGenomics (NEO) Stock Trades Up, Here Is Why

NeoGenomics (NEO) Stock Trades Up, Here Is Why

NEO : 14.11 (-4.21%)
NeoGenomics Launches FDA-Approved PTEN IHC Companion Diagnostic for Prostate Cancer

Available within NEO PanTracer™ Pro for prostate cancer and as a standalone test, PTEN IHC CDx identifies patients who may be eligible for TRUQAP ®

NEO : 14.11 (-4.21%)
NeoGenomics to Report Second Quarter 2026 Financial Results on July 28, 2026

NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced that it will report its second quarter 2026 financial results...

NEO : 14.11 (-4.21%)
A Look Back at Testing & Diagnostics Services Stocks’ Q1 Earnings: NeoGenomics (NASDAQ:NEO) Vs The Rest Of The Pack

A Look Back at Testing & Diagnostics Services Stocks’ Q1 Earnings: NeoGenomics (NASDAQ:NEO) Vs The Rest Of The Pack

NEO : 14.11 (-4.21%)
NeoGenomics Appoints Carolyn Starrett to its Board of Directors

NeoGenomics, Inc. (NASDAQ: NEO) , a leading provider of oncology diagnostic solutions that enable precision medicine, today announced the appointment of Carolyn Starrett to its...

NEO : 14.11 (-4.21%)
1 Unprofitable Stock for Long-Term Investors and 2 Facing Headwinds

1 Unprofitable Stock for Long-Term Investors and 2 Facing Headwinds

AMPL : 9.18 (-2.13%)
CNXC : 22.20 (+5.87%)
NEO : 14.11 (-4.21%)
NeoGenomics Announces Pricing of Offering of $275 Million Convertible Senior Notes

NeoGenomics, Inc. (NASDAQ: NEO) , a leading provider of oncology diagnostic solutions that enable precision medicine, announced today the pricing of its previously announced private offering of...

NEO : 14.11 (-4.21%)
NeoGenomics Announces Proposed Offering of $275 Million Convertible Senior Notes

NeoGenomics, Inc. (NASDAQ: NEO) , a leading provider of oncology diagnostic solutions that enable precision medicine, announced today that it has commenced a private offering of $275 million aggregate...

NEO : 14.11 (-4.21%)
NeoGenomics to Present New Research at ASCO Annual Meeting 2026

Presentations highlight advances in MRD, precision oncology, and real-world evidence across solid tumors and hematologic malignancies

NEO : 14.11 (-4.21%)
NeoGenomics to Participate in Upcoming Investor Conferences

NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced the Company will participate in the following investor conferences:...

NEO : 14.11 (-4.21%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Average short term outlook on maintaining the current direction.

Relative Strength just crossed below 70%. The market has dropped from overbought territory. Beware of a potential mean reversion.

See More Share

Business Summary

NeoGenomics, Inc. is a high-complexity CLIA-certified clinical laboratory that specializes in cancer genetics diagnostic testing, the fastest growing segment of the laboratory industry. The company's testing services include cytogenetics, fluorescence in-situ hybridization, flow cytometry, morphology...

See More

Key Turning Points

3rd Resistance Point 15.30
2nd Resistance Point 15.00
1st Resistance Point 14.55
Last Price 14.11
1st Support Level 13.81
2nd Support Level 13.51
3rd Support Level 13.06

See More

52-Week High 15.57
Last Price 14.11
Fibonacci 61.8% 11.43
Fibonacci 50% 10.14
Fibonacci 38.2% 8.86
52-Week Low 4.72

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.